CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...